SCHEMBL5283033

SCHEMBL5283033

NC(CCCCNC(=O)COCc1ccccc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 3/20 0.49
DPP7 Q9UHL4 3/20 0.49
DPP4 P27487 2/20 0.48
DPP9 Q86TI2 2/20 0.48
SLC1A1 P43005 2/20 0.48
ANPEP P15144 1/20 0.47
SLC1A3 P43003 1/20 0.47
LTA4H P09960 4/20 0.46
OTC P00480 1/20 0.44
FOLH1 Q04609 1/20 0.43
C3AR1 Q16581 1/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283021 1.00 DPP8 (0.49) DPP8DPP7DPP4DPP9SLC1A1
SCHEMBL3448812 0.82 TRPV1 (0.61) OTCKMT2AALDH1A1HPGD
SCHEMBL23471165 0.82 TRPV1 (0.47) LTA4HHPGD
SCHEMBL5816135 0.82 DPP8 (0.69) DPP8DPP7DPP4DPP9SLC1A1
L-Lysine-Phenoxyacetic Acid SCHEMBL31711072 0.82 RECQL (0.55) LTA4HOTCKMT2AHPGD
SCHEMBL453671 0.82 DPP8 (0.69) DPP8DPP7DPP4DPP9SLC1A1
SCHEMBL464672 0.82 DPP8 (0.69) DPP8DPP7DPP4DPP9SLC1A1
SCHEMBL10653325 0.81 DPP8 (0.60) DPP8DPP7DPP4DPP9SLC1A1
SCHEMBL7428900 0.81 SLC1A1 (0.48) DPP8DPP7DPP4DPP9SLC1A1
SCHEMBL17117364 0.81 TRPV1 (0.63) KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US claimed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO claimed
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP disclosed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 DPP8 2744/4885DPP7 2134/4885DPP4 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.